| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.02 | 0.8 |